187 related articles for article (PubMed ID: 22338583)
1. Melanoma in situ treated successfully using imiquimod after nonclearance with surgery: review of the literature.
Ellis LZ; Cohen JL; High W; Stewart L
Dermatol Surg; 2012 Jun; 38(6):937-46. PubMed ID: 22338583
[TBL] [Abstract][Full Text] [Related]
2. Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery.
Erickson C; Miller SJ
Int J Dermatol; 2010 May; 49(5):482-91. PubMed ID: 20534080
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream.
Ray CM; Kluk M; Grin CM; Grant-Kels JM
Int J Dermatol; 2005 May; 44(5):428-34. PubMed ID: 15869545
[TBL] [Abstract][Full Text] [Related]
4. Interventions for melanoma in situ, including lentigo maligna.
Tzellos T; Kyrgidis A; Mocellin S; Chan AW; Pilati P; Apalla Z
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010308. PubMed ID: 25526608
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisions.
Hyde MA; Hadley ML; Tristani-Firouzi P; Goldgar D; Bowen GM
Arch Dermatol; 2012 May; 148(5):592-6. PubMed ID: 22431716
[TBL] [Abstract][Full Text] [Related]
6. [Lentigo maligna treated with 5% imiquimod cream].
Martín T; Ojeda A; Martínez S; Vera A
Actas Dermosifiliogr; 2005 Dec; 96(10):700-2. PubMed ID: 16476324
[TBL] [Abstract][Full Text] [Related]
7. Imiquimod and lentigo maligna: a search for prognostic features in a clinicopathological study with long-term follow-up.
Powell AM; Robson AM; Russell-Jones R; Barlow RJ
Br J Dermatol; 2009 May; 160(5):994-8. PubMed ID: 19222462
[TBL] [Abstract][Full Text] [Related]
8. Lentigo maligna (melanoma in situ) treated with imiquimod cream 5%: 12 case reports.
Spenny ML; Walford J; Werchniak AE; Beltrani V; Brennick JB; Storm CA; Perry AE; Chapman MS
Cutis; 2007 Feb; 79(2):149-52. PubMed ID: 17388218
[TBL] [Abstract][Full Text] [Related]
9. Topical imiquimod immunotherapy in the management of lentigo maligna.
Powell AM; Russell-Jones R; Barlow RJ
Clin Exp Dermatol; 2004 Jan; 29(1):15-21. PubMed ID: 14723712
[TBL] [Abstract][Full Text] [Related]
10. Topical imiquimod therapy for lentigo maligna.
Mahoney MH; Joseph MG; Temple C
Ann Plast Surg; 2008 Oct; 61(4):419-24. PubMed ID: 18812714
[TBL] [Abstract][Full Text] [Related]
11. Mohs surgery for the treatment of melanoma in situ: a review.
Dawn ME; Dawn AG; Miller SJ
Dermatol Surg; 2007 Apr; 33(4):395-402. PubMed ID: 17430372
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of persistent melanoma in situ with 5% imiquimod cream.
Muñoz CM; Sánchez JL; Martín-García RF
Dermatol Surg; 2004 Dec; 30(12 Pt 2):1543-5. PubMed ID: 15606836
[TBL] [Abstract][Full Text] [Related]
13. Treatment of lentigo maligna with imiquimod before staged excision.
Cotter MA; McKenna JK; Bowen GM
Dermatol Surg; 2008 Feb; 34(2):147-51. PubMed ID: 18093206
[TBL] [Abstract][Full Text] [Related]
14. Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.
van der Geer S; Martens J; van Roij J; Brand E; Ostertag JU; Verhaegh ME; Neumann HA; Krekels GA
Br J Dermatol; 2012 Jul; 167(1):110-5. PubMed ID: 22385074
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the cellular infiltrate during successful topical treatment of lentigo maligna with imiquimod.
Michalopoulos P; Yawalkar N; Brönnimann M; Kappeler A; Braathen LR
Br J Dermatol; 2004 Oct; 151(4):903-6. PubMed ID: 15491436
[TBL] [Abstract][Full Text] [Related]
16. Use of in vivo confocal microscopy in malignant melanoma: an aid in diagnosis and assessment of surgical and nonsurgical therapeutic approaches.
Curiel-Lewandrowski C; Williams CM; Swindells KJ; Tahan SR; Astner S; Frankenthaler RA; González S
Arch Dermatol; 2004 Sep; 140(9):1127-32. PubMed ID: 15381554
[TBL] [Abstract][Full Text] [Related]
17. Histologic resolution of melanoma in situ (lentigo maligna) with 5% imiquimod cream.
Chapman MS; Spencer SK; Brennick JB
Arch Dermatol; 2003 Jul; 139(7):943-4. PubMed ID: 12873902
[No Abstract] [Full Text] [Related]
18. Long-term follow-up of a hemifacial lentigo maligna treated using 5% imiquimod.
Ramsdell AM; Zeitouni N
Dermatol Surg; 2009 Feb; 35(2):287-90. PubMed ID: 19215272
[No Abstract] [Full Text] [Related]
19. Mohs micrographic surgery is accurate 95.1% of the time for melanoma in situ: a prospective study of 167 cases.
Bene NI; Healy C; Coldiron BM
Dermatol Surg; 2008 May; 34(5):660-4. PubMed ID: 18261099
[TBL] [Abstract][Full Text] [Related]
20. [Imiquimod treatment of lentigo maligna to dermoscopic and histologic clearance].
Lorentzen HF; Weismann K
Ugeskr Laeger; 2005 Sep; 167(39):3696-7. PubMed ID: 16219219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
